Arix Bioscience PLC | WebDisclosure

PRESS RELEASE

published on 11/03/2023 at 17:30, 2 years 1 month ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/02/2023 at 19:20, 2 years 1 month ago

PDMR Notification & Director Shareholding
PRESS RELEASE

published on 11/01/2023 at 17:30, 2 years 1 month ago

Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in Phase 1/1b Clinical Trial of SOR102
PRESS RELEASE

published on 10/24/2023 at 08:00, 2 years 1 month ago

Portfolio company Harpoon Therapeutics announces up to $150 million private placement
PRESS RELEASE

published on 10/06/2023 at 08:00, 2 years 2 months ago

Unaudited NAV for September 2023
PRESS RELEASE

published on 09/27/2023 at 08:01, 2 years 2 months ago

Interim Results for the Six Months Ended 30 June 2023
PRESS RELEASE

published on 09/27/2023 at 08:00, 2 years 2 months ago

Board Change
PRESS RELEASE

published on 09/14/2023 at 08:01, 2 years 3 months ago

Notice of Results and Investor Presentation
PRESS RELEASE

published on 09/14/2023 at 08:00, 2 years 3 months ago

Unaudited NAV for August 2023
PRESS RELEASE

published on 08/07/2023 at 08:00, 2 years 4 months ago

Unaudited NAV for July 2023

Published on 12/12/2025 at 18:00, 1 day 19 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 1 day 19 hours ago

Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
Published on 12/12/2025 at 09:15, 2 days 4 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/12/2025 at 09:15, 2 days 4 hours ago

MODIFICATION DE CAPITAL
Published on 12/11/2025 at 19:23, 2 days 18 hours ago

Eiffage is joining the CAC 40 index

News